WHWK
NASDAQ · Biotechnology
Whitehawk Therapeutics Inc
$3.97
+0.03 (+0.76%)
Open$3.89
Previous Close$3.94
Day High$4.00
Day Low$3.89
52W High$5.50
52W Low$1.57
Volume—
Avg Volume680.9K
Market Cap232.43M
P/E Ratio—
EPS$-1.44
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+336.0% upside
Current
$3.97
$3.97
Target
$17.31
$17.31
$14.24
$17.31 avg
$28.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.88M | 11.42M | 8.91M |
| Net Income | -25,578,624 | -29,620,125 | 2.41M |
| Profit Margin | -288.3% | -273.9% | 27.1% |
| EBITDA | -33,224,694 | -40,611,759 | 4.31M |
| Free Cash Flow | — | — | 1.46M |
| Rev Growth | -22.3% | -22.3% | +22.0% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |